Athira - Hold accumulateAthira Pharma's explosive growth potential is attributed to its innovative therapies aimed at neurological disorders, such as Alzheimer’s, Parkinson’s disease dementia, and dementia with Lewy bodies. The flagship molecule, ATH-107 (also known as fosgonimeton or fosgo), currently in advanced clinical